| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.83B | 61.31B | 50.44B | 52.60B | 48.60B | 41.55B |
| Gross Profit | 47.83B | 52.15B | 45.31B | 47.20B | 44.88B | 40.35B |
| EBITDA | 1.29B | 10.75B | 8.38B | 5.35B | 6.88B | 7.23B |
| Net Income | 4.43B | 6.53B | 4.41B | 2.08B | 3.44B | 3.40B |
Balance Sheet | ||||||
| Total Assets | 3.23T | 3.28T | 3.16T | 3.15T | 3.14T | 3.54T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 215.12B | 206.59B | 197.12B | 249.80B | 646.47B |
| Total Debt | 117.20B | 160.81B | 119.01B | 134.47B | 133.21B | 545.66B |
| Total Liabilities | 3.08T | 3.13T | 3.03T | 3.00T | 3.01T | 3.38T |
| Stockholders Equity | 143.60B | 150.44B | 135.82B | 143.63B | 133.55B | 155.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.07B | 7.40B | 0.00 | -471.44B | 445.89B |
| Operating Cash Flow | 0.00 | 5.95B | 10.25B | 0.00 | -469.31B | 450.23B |
| Investing Cash Flow | 0.00 | -111.05B | 56.97B | 94.19B | 75.43B | -194.68B |
| Financing Cash Flow | 0.00 | 93.11B | 40.08B | 12.22B | -1.21B | -1.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥189.55B | 15.21 | ― | 2.23% | 31.23% | 66.11% | |
71 Outperform | ¥107.18B | 13.87 | ― | 3.35% | 26.92% | 35.22% | |
70 Outperform | ¥175.81B | 16.10 | 3.68% | 2.26% | 23.47% | 44.30% | |
68 Neutral | ¥187.70B | 18.03 | ― | 2.56% | 42.06% | 29.62% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥95.16B | 14.84 | ― | 2.89% | 23.58% | 50.43% | |
65 Neutral | ¥158.28B | 11.05 | ― | 2.29% | 9.41% | 45.91% |